Ching Ting Loke, M.B.,B.Ch., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Myeloid, Acute | 14 | 2021 | 3626 | 1.730 |
Why?
|
Graft vs Leukemia Effect | 1 | 2021 | 121 | 0.720 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2021 | 93 | 0.700 |
Why?
|
fms-Like Tyrosine Kinase 3 | 3 | 2020 | 494 | 0.610 |
Why?
|
Leukemia, Myeloid | 1 | 2021 | 693 | 0.590 |
Why?
|
Transplantation Conditioning | 2 | 2021 | 1601 | 0.570 |
Why?
|
Stem Cell Transplantation | 3 | 2020 | 1596 | 0.560 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2018 | 287 | 0.540 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 2 | 2017 | 355 | 0.500 |
Why?
|
Chromosomes, Human | 1 | 2017 | 437 | 0.490 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2015 | 192 | 0.480 |
Why?
|
Aminoglycosides | 1 | 2014 | 161 | 0.450 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2021 | 5716 | 0.430 |
Why?
|
Research | 1 | 2020 | 1977 | 0.380 |
Why?
|
Aneuploidy | 1 | 2015 | 573 | 0.380 |
Why?
|
Translocation, Genetic | 1 | 2017 | 1391 | 0.370 |
Why?
|
Gene Expression Regulation, Leukemic | 3 | 2018 | 658 | 0.330 |
Why?
|
Graft vs Host Disease | 2 | 2020 | 3049 | 0.310 |
Why?
|
Chromatin | 1 | 2017 | 2980 | 0.240 |
Why?
|
Palliative Care | 1 | 2020 | 3641 | 0.240 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3828 | 0.230 |
Why?
|
Amsacrine | 1 | 2020 | 19 | 0.190 |
Why?
|
Cytarabine | 2 | 2020 | 695 | 0.180 |
Why?
|
Apoproteins | 1 | 2020 | 45 | 0.180 |
Why?
|
Myeloablative Agonists | 1 | 2020 | 210 | 0.170 |
Why?
|
Busulfan | 1 | 2020 | 259 | 0.170 |
Why?
|
Vidarabine | 1 | 2020 | 337 | 0.160 |
Why?
|
Blood Component Transfusion | 1 | 2020 | 141 | 0.160 |
Why?
|
Transcription Factors | 2 | 2018 | 12158 | 0.160 |
Why?
|
Transferrin | 1 | 2020 | 283 | 0.160 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2021 | 10393 | 0.140 |
Why?
|
Tranexamic Acid | 1 | 2020 | 174 | 0.140 |
Why?
|
HLA-B7 Antigen | 1 | 2017 | 48 | 0.140 |
Why?
|
Transplantation, Homologous | 3 | 2021 | 4838 | 0.140 |
Why?
|
Mutation | 3 | 2018 | 30211 | 0.140 |
Why?
|
GATA2 Transcription Factor | 1 | 2017 | 158 | 0.140 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2017 | 130 | 0.140 |
Why?
|
Patient Care | 1 | 2021 | 628 | 0.120 |
Why?
|
Glycopeptides | 1 | 2017 | 225 | 0.120 |
Why?
|
Remission Induction | 1 | 2021 | 2408 | 0.120 |
Why?
|
Arginase | 1 | 2015 | 81 | 0.120 |
Why?
|
Neoplasm, Residual | 1 | 2019 | 1012 | 0.120 |
Why?
|
Infection Control | 1 | 2020 | 984 | 0.100 |
Why?
|
Anti-Infective Agents | 1 | 2020 | 986 | 0.100 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 1604 | 0.100 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2015 | 645 | 0.100 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13650 | 0.090 |
Why?
|
Antigens, Neoplasm | 2 | 2017 | 1997 | 0.090 |
Why?
|
Arginine | 1 | 2015 | 931 | 0.090 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6844 | 0.090 |
Why?
|
Myelodysplastic Syndromes | 1 | 2020 | 1399 | 0.090 |
Why?
|
Acute Disease | 1 | 2021 | 7236 | 0.090 |
Why?
|
Azacitidine | 1 | 2012 | 336 | 0.090 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1752 | 0.080 |
Why?
|
Cell Differentiation | 2 | 2018 | 11657 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2531 | 0.080 |
Why?
|
Humans | 19 | 2021 | 767040 | 0.080 |
Why?
|
Leukemia | 1 | 2017 | 1518 | 0.080 |
Why?
|
Immune System Diseases | 1 | 2011 | 253 | 0.080 |
Why?
|
HEK293 Cells | 1 | 2018 | 4280 | 0.080 |
Why?
|
Binding Sites | 1 | 2017 | 6014 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 1492 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4210 | 0.070 |
Why?
|
Cell Survival | 1 | 2017 | 5750 | 0.070 |
Why?
|
Receptors, GABA-A | 1 | 2011 | 624 | 0.070 |
Why?
|
Viral Matrix Proteins | 1 | 2007 | 193 | 0.070 |
Why?
|
Base Sequence | 1 | 2017 | 12414 | 0.060 |
Why?
|
Immune System | 1 | 2011 | 799 | 0.060 |
Why?
|
Anesthetics | 1 | 2011 | 525 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9410 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8048 | 0.060 |
Why?
|
Alleles | 1 | 2015 | 6893 | 0.060 |
Why?
|
Cytomegalovirus | 1 | 2007 | 751 | 0.050 |
Why?
|
Cells, Cultured | 1 | 2018 | 18989 | 0.050 |
Why?
|
Cytomegalovirus Infections | 1 | 2007 | 836 | 0.050 |
Why?
|
Adult | 6 | 2021 | 223317 | 0.050 |
Why?
|
Respiratory Therapy | 1 | 2021 | 124 | 0.040 |
Why?
|
Oral Hygiene | 1 | 2021 | 132 | 0.040 |
Why?
|
Prognosis | 1 | 2021 | 29963 | 0.040 |
Why?
|
Relaxation Therapy | 1 | 2021 | 181 | 0.040 |
Why?
|
Nutritional Support | 1 | 2021 | 178 | 0.040 |
Why?
|
Phenotype | 1 | 2017 | 16718 | 0.040 |
Why?
|
Phosphoproteins | 1 | 2007 | 2448 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2012 | 3114 | 0.040 |
Why?
|
Tissue Donors | 1 | 2007 | 2387 | 0.040 |
Why?
|
Acupuncture Therapy | 1 | 2021 | 485 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2007 | 3212 | 0.030 |
Why?
|
Enzyme Therapy | 1 | 2015 | 8 | 0.030 |
Why?
|
Methylation | 1 | 2017 | 1076 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2021 | 939 | 0.030 |
Why?
|
Middle Aged | 6 | 2021 | 223233 | 0.030 |
Why?
|
Glycosylation | 1 | 2017 | 1099 | 0.030 |
Why?
|
Transcription Factor AP-1 | 1 | 2015 | 321 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2015 | 635 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 2007 | 4268 | 0.030 |
Why?
|
Lysosomal-Associated Membrane Protein 1 | 1 | 2012 | 25 | 0.020 |
Why?
|
Psychotherapy | 1 | 2021 | 1653 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2020 | 81659 | 0.020 |
Why?
|
Cysteine Loop Ligand-Gated Ion Channel Receptors | 1 | 2011 | 4 | 0.020 |
Why?
|
Picrotoxin | 1 | 2011 | 61 | 0.020 |
Why?
|
Muscimol | 1 | 2011 | 70 | 0.020 |
Why?
|
Bicuculline | 1 | 2011 | 96 | 0.020 |
Why?
|
GABA Antagonists | 1 | 2011 | 119 | 0.020 |
Why?
|
GABA-A Receptor Agonists | 1 | 2011 | 86 | 0.020 |
Why?
|
Cell Line | 2 | 2017 | 15567 | 0.020 |
Why?
|
Mice, SCID | 1 | 2015 | 2626 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2012 | 793 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2017 | 1965 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3760 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8504 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2021 | 3446 | 0.020 |
Why?
|
Young Adult | 3 | 2020 | 59980 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2015 | 6106 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 1331 | 0.020 |
Why?
|
Virus Activation | 1 | 2007 | 322 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2011 | 862 | 0.020 |
Why?
|
Epitopes | 1 | 2012 | 2526 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6507 | 0.020 |
Why?
|
Male | 6 | 2021 | 364203 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2011 | 1175 | 0.010 |
Why?
|
Aged | 4 | 2020 | 171319 | 0.010 |
Why?
|
Female | 5 | 2021 | 396660 | 0.010 |
Why?
|
Monocytes | 1 | 2011 | 2598 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 17097 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2017 | 10254 | 0.010 |
Why?
|
Quality of Life | 1 | 2020 | 13485 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40154 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2012 | 4648 | 0.010 |
Why?
|
Cytokines | 1 | 2012 | 7446 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23621 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 65295 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 59548 | 0.010 |
Why?
|
Infant | 1 | 2015 | 36485 | 0.010 |
Why?
|
Child, Preschool | 1 | 2015 | 42606 | 0.010 |
Why?
|
Child | 1 | 2015 | 80771 | 0.000 |
Why?
|
Adolescent | 1 | 2015 | 89046 | 0.000 |
Why?
|
Animals | 1 | 2015 | 168965 | 0.000 |
Why?
|